These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 347003)

  • 21. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine.
    Ashorn RG; Räsänen L; Marnela KM; Krohn KJ
    Clin Exp Immunol; 1979 Jul; 37(1):50-7. PubMed ID: 385187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity.
    Rocklin RE; Blidy A; Butler J; Minowada J
    J Immunol; 1981 Aug; 127(2):534-9. PubMed ID: 7019325
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of tilorone-induced mouse migration inhibitory factor by affinity chromatography and isoelectric focusing.
    Fahlbusch B; Zschiesche W; Römer W
    Acta Biol Med Ger; 1981; 40(2):147-52. PubMed ID: 7023160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte migration inhibitory factor (LIF) to sperm from autoimmune men in infertile couples.
    Mathur S; Pathak S; Kandel A; Ziegler J; Rust PF; Wiliamson HO
    J Immunol; 1986 Jun; 136(12):4444-50. PubMed ID: 3519771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of MIF and the role of macrophage associated esterases in the response of the macrophage to MIF.
    Remold HG; Mednis AD; McCarthy PL
    Adv Exp Med Biol; 1979; 114():465-8. PubMed ID: 380297
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.
    Meshulam DH; Blair HE; Wong BL; Charm S; Minowada J; Rocklin RE
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):601-5. PubMed ID: 6952211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of serum fractions from cancer patients on leukocyte migration out of capillary tubes].
    Novikov DK; Shmakov AP; Borisenko ID
    Biull Eksp Biol Med; 1978 Nov; 86(11):568-72. PubMed ID: 363203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes.
    Klempner MS; Rocklin RE
    J Immunol; 1982 May; 128(5):2040-3. PubMed ID: 7037959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
    Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucocyte migration inhibition factor (LIF) and antithrombin III (AT III).
    Weber TH; Mäkinen T; Welin MG
    J Clin Lab Immunol; 1980 Jul; 4(1):47-8. PubMed ID: 7007650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of calcium in the activation of neutrophils by leukocyte inhibitory factor (LIF).
    Borish L; Rosenbaum R; Rocklin R
    Lymphokine Res; 1987; 6(4):341-9. PubMed ID: 3323675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin effect on lymphokine production in multiple sclerosis.
    Willoughby EW; Dupont B; Good RA
    Ann Neurol; 1979 Apr; 5(4):391-3. PubMed ID: 375809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte inhibitory factor (LIF) in granuloma annulare: a comparative study between the generalized and the localized types.
    Friedman-Birnbaum R; Gilhar A; Haim S; Golan DT
    Acta Derm Venereol; 1983; 63(3):242-3. PubMed ID: 6192642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor.
    Zeng FY; Weiser WY; Kratzin H; Stahl B; Karas M; Gabius HJ
    Arch Biochem Biophys; 1993 May; 303(1):74-80. PubMed ID: 7683862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An effective single-stage method of obtaining elastase and cathepsin G from human leukocytes].
    Neshkova EA; Dotsenko VL; Larionova NI; Iarovaia GA
    Biokhimiia; 1993 Dec; 58(12):1886-92. PubMed ID: 8292650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The requirement for esterase activation in the anti-immunoglobulin-triggered movement of B lymphocytes.
    Becker EL; Unanue ER
    J Immunol; 1976 Jul; 117(1):27-32. PubMed ID: 1084365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of N-substituted arginine compounds on blood pressure in anesthetized rats.
    Thomas G; Myers A; Farhat M; Cathapermal S; Ramwell PW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):875-8. PubMed ID: 1602391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.